vs

Side-by-side financial comparison of MasterBrand, Inc. (MBC) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

MasterBrand, Inc. is the larger business by last-quarter revenue ($618.0M vs $321.1M, roughly 1.9× MADRIGAL PHARMACEUTICALS, INC.). On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs -6.4%). MADRIGAL PHARMACEUTICALS, INC. produced more free cash flow last quarter ($-133.8M vs $-146.2M).

Master Lock is an American company that sells padlocks, combination locks, safes, and related security products. Now a subsidiary of Fortune Brands Innovations, Master Lock Company LLC was formed in 1921 by locksmith-inventor Harry Soref and is headquartered in Oak Creek, Wisconsin. In 1970, the company was purchased by American Brands from Soref's heirs. American Brands was later renamed to Fortune Brands, which then split on October 3, 2011, to create the Fortune Brands Home & Security comp...

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

MBC vs MDGL — Head-to-Head

Bigger by revenue
MBC
MBC
1.9× larger
MBC
$618.0M
$321.1M
MDGL
Growing faster (revenue YoY)
MDGL
MDGL
+217.2% gap
MDGL
210.8%
-6.4%
MBC
More free cash flow
MDGL
MDGL
$12.3M more FCF
MDGL
$-133.8M
$-146.2M
MBC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MBC
MBC
MDGL
MDGL
Revenue
$618.0M
$321.1M
Net Profit
$-58.6M
Gross Margin
25.3%
Operating Margin
-18.6%
Net Margin
-18.2%
Revenue YoY
-6.4%
210.8%
Net Profit YoY
1.4%
EPS (diluted)
$-0.12
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MBC
MBC
MDGL
MDGL
Q1 26
$618.0M
Q4 25
$644.6M
$321.1M
Q3 25
$698.9M
$287.3M
Q2 25
$730.9M
$212.8M
Q1 25
$660.3M
$137.3M
Q4 24
$667.7M
$103.3M
Q3 24
$718.1M
$62.2M
Q2 24
$676.5M
Net Profit
MBC
MBC
MDGL
MDGL
Q1 26
Q4 25
$-42.0M
$-58.6M
Q3 25
$18.1M
$-114.2M
Q2 25
$37.3M
$-42.3M
Q1 25
$13.3M
$-73.2M
Q4 24
$14.0M
$-59.4M
Q3 24
$29.1M
$-107.0M
Q2 24
$45.3M
Gross Margin
MBC
MBC
MDGL
MDGL
Q1 26
25.3%
Q4 25
26.0%
Q3 25
31.2%
Q2 25
32.8%
Q1 25
30.6%
96.7%
Q4 24
30.4%
Q3 24
33.1%
Q2 24
34.1%
Operating Margin
MBC
MBC
MDGL
MDGL
Q1 26
Q4 25
-4.2%
-18.6%
Q3 25
6.0%
-39.7%
Q2 25
9.2%
-22.2%
Q1 25
5.6%
-57.8%
Q4 24
5.6%
-64.8%
Q3 24
8.0%
-187.1%
Q2 24
11.5%
Net Margin
MBC
MBC
MDGL
MDGL
Q1 26
Q4 25
-6.5%
-18.2%
Q3 25
2.6%
-39.8%
Q2 25
5.1%
-19.9%
Q1 25
2.0%
-53.4%
Q4 24
2.1%
-57.5%
Q3 24
4.1%
-172.0%
Q2 24
6.7%
EPS (diluted)
MBC
MBC
MDGL
MDGL
Q1 26
$-0.12
Q4 25
$-0.32
$-2.55
Q3 25
$0.14
$-5.08
Q2 25
$0.29
$-1.90
Q1 25
$0.10
$-3.32
Q4 24
$0.10
$-2.50
Q3 24
$0.22
$-4.92
Q2 24
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MBC
MBC
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$138.4M
$198.7M
Total DebtLower is stronger
$1.1B
$339.9M
Stockholders' EquityBook value
$1.3B
$602.7M
Total Assets
$3.1B
$1.3B
Debt / EquityLower = less leverage
0.82×
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MBC
MBC
MDGL
MDGL
Q1 26
$138.4M
Q4 25
$183.3M
$198.7M
Q3 25
$114.8M
$295.7M
Q2 25
$120.1M
$186.2M
Q1 25
$113.5M
$183.6M
Q4 24
$120.6M
$100.0M
Q3 24
$108.4M
$232.7M
Q2 24
$189.4M
Total Debt
MBC
MBC
MDGL
MDGL
Q1 26
$1.1B
Q4 25
$339.9M
Q3 25
$339.8M
Q2 25
$118.4M
Q1 25
$118.0M
Q4 24
$1.0B
$117.6M
Q3 24
$1.1B
$117.1M
Q2 24
Stockholders' Equity
MBC
MBC
MDGL
MDGL
Q1 26
$1.3B
Q4 25
$1.3B
$602.7M
Q3 25
$1.4B
$625.7M
Q2 25
$1.4B
$696.0M
Q1 25
$1.3B
$710.6M
Q4 24
$1.3B
$754.4M
Q3 24
$1.3B
$777.2M
Q2 24
$1.3B
Total Assets
MBC
MBC
MDGL
MDGL
Q1 26
$3.1B
Q4 25
$3.1B
$1.3B
Q3 25
$3.0B
$1.4B
Q2 25
$3.0B
$1.0B
Q1 25
$3.0B
$996.6M
Q4 24
$2.9B
$1.0B
Q3 24
$3.0B
$1.1B
Q2 24
$2.4B
Debt / Equity
MBC
MBC
MDGL
MDGL
Q1 26
0.82×
Q4 25
0.56×
Q3 25
0.54×
Q2 25
0.17×
Q1 25
0.17×
Q4 24
0.79×
0.16×
Q3 24
0.83×
0.15×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MBC
MBC
MDGL
MDGL
Operating Cash FlowLast quarter
$-133.0M
$-133.5M
Free Cash FlowOCF − Capex
$-146.2M
$-133.8M
FCF MarginFCF / Revenue
-23.7%
-41.7%
Capex IntensityCapex / Revenue
2.1%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MBC
MBC
MDGL
MDGL
Q1 26
$-133.0M
Q4 25
$86.9M
$-133.5M
Q3 25
$55.4M
$79.8M
Q2 25
$84.8M
$-47.1M
Q1 25
$-31.4M
$-88.9M
Q4 24
$115.1M
$-104.5M
Q3 24
$80.8M
$-67.0M
Q2 24
$77.4M
Free Cash Flow
MBC
MBC
MDGL
MDGL
Q1 26
$-146.2M
Q4 25
$52.5M
$-133.8M
Q3 25
$39.5M
$79.0M
Q2 25
$66.7M
Q1 25
$-41.2M
Q4 24
$68.8M
$-104.7M
Q3 24
$64.5M
$-67.8M
Q2 24
$66.1M
FCF Margin
MBC
MBC
MDGL
MDGL
Q1 26
-23.7%
Q4 25
8.1%
-41.7%
Q3 25
5.7%
27.5%
Q2 25
9.1%
Q1 25
-6.2%
Q4 24
10.3%
-101.3%
Q3 24
9.0%
-109.0%
Q2 24
9.8%
Capex Intensity
MBC
MBC
MDGL
MDGL
Q1 26
2.1%
Q4 25
5.3%
0.1%
Q3 25
2.3%
0.3%
Q2 25
2.5%
0.0%
Q1 25
1.5%
0.0%
Q4 24
6.9%
0.2%
Q3 24
2.3%
1.3%
Q2 24
1.7%
Cash Conversion
MBC
MBC
MDGL
MDGL
Q1 26
Q4 25
Q3 25
3.06×
Q2 25
2.27×
Q1 25
-2.36×
Q4 24
8.22×
Q3 24
2.78×
Q2 24
1.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MBC
MBC

Segment breakdown not available.

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons